Bretazenil

DB21038ExperimentalSmall molecule

Bretazenil is a small molecule drug. The usage of the INN stem '-nil' in the name indicates that Bretazenil is a benzodiazepine receptor antagonist/agonist. Bretazenil has a monoisotopic molecular weight...

Formula / weight: C₁₉H₂₀BrN₃O₃ · 418.291 g/mol (avg)
Code names: RO 16-6028/000 · RO-F61816-6028/000

Resolves to

Compound

UNIIOSZ0E9DGOJCAS84379-13-5ChEMBLCHEMBL366947

Structure

InChIKeyLWUDDYHYYNNIQI-ZDUSSCGKSA-NSMILES[H][C@@]12CCCN1C(=O)C1=C(C=CC=C1Br)N1C=NC(C(=O)OC(C)(C)C)=C21

Targets

P30536TSPO

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Bretazenil, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account